Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CIQ 是亚基选择性NMDA 受体增强剂,可作用于NR2C 或NR2D 亚基。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 273 | 现货 | ||
2 mg | ¥ 389 | 现货 | ||
5 mg | ¥ 583 | 现货 | ||
10 mg | ¥ 955 | 现货 | ||
25 mg | ¥ 1,870 | 现货 | ||
50 mg | ¥ 2,780 | 现货 | ||
100 mg | ¥ 3,970 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 658 | 现货 |
产品描述 | CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit. EC50 value: 2.7 μM for NR2C and 2.8 μM for NR2D. |
靶点活性 | NR2C:2.7 μM(EC50), NR2D:2.8 μM(EC50) |
体外活性 | CIQ reduces associated behaviours in schizophrenia models and potentially enhances dopamine release in Parkinson's disease models. NMDA receptor CIQ increases channel opening frequency of recombinant NR2Cor NR2D containing receptors by two-fold (EC50 = 2.7 and 2.8 μM, respectively). It has no effect on NR2A or NR2B subtypes. CIQ does not alter the EC50 values for glutamate or glycine on channel opening. CIQ increases channel opening efficiency and enhances NMDA receptor responses. |
分子量 | 467.94 |
分子式 | C26H26ClNO5 |
CAS No. | 486427-17-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (106.85 mM)
H2O: insoluble
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.137 mL | 10.6851 mL | 21.3703 mL | 53.4257 mL |
5 mM | 0.4274 mL | 2.137 mL | 4.2741 mL | 10.6851 mL | |
10 mM | 0.2137 mL | 1.0685 mL | 2.137 mL | 5.3426 mL | |
20 mM | 0.1069 mL | 0.5343 mL | 1.0685 mL | 2.6713 mL | |
50 mM | 0.0427 mL | 0.2137 mL | 0.4274 mL | 1.0685 mL | |
100 mM | 0.0214 mL | 0.1069 mL | 0.2137 mL | 0.5343 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
CIQ 486427-17-2 Neuroscience NMDAR Ionotropic glutamate receptors Inhibitor inhibit iGluR inhibitor